The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAXI.L Regulatory News (AXI)

  • There is currently no data for AXI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Company update

18 Aug 2022 07:00

RNS Number : 3933W
Axiom European Financial Debt Fd Ld
18 August 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. WITH THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

FOR IMMEDIATE RELEASE

 

18 August 2022

Axiom European Financial Debt Fund Limited

Company update

The Board of Axiom European Financial Debt Fund Limited (the "Company") notes that the regulatory transition that the Company's investment objective has sought to exploit since IPO is now drawing to a close. The Board also notes the persistent discount on, and limited liquidity in, the Company's shares despite the NAV performance track record of the Company which, in the 3- and 5-year periods to 15 August 2022, was by a substantial margin the best in the AIC Debt - Loans & Bonds sector at 6.85% p.a. and 5.23% p.a. respectively. Consequently, and in the light of feedback from a significant proportion of the Company's shareholders (the "Shareholders"), the Board has determined that it would not be in Shareholders' best interests to continue the Company in its present form and intends to put forward alternative proposals to Shareholders.

The Board has been encouraged by the positive feedback from Shareholders in respect of the Company's strategy and the potential for it to be evolved to provide attractive returns into the future. The Board also notes that the investment manager, Axiom Alternative Investments SARL ("Axiom") already manages a range of other funds which follow similar strategies with success and which have seen substantial inflows of investor capital over the past two or three years. Accordingly, due to the challenges noted above, the Board intends to offer Shareholders the option of receiving cash at NAV (less costs, including any portfolio realisation expenses) for some or all of their shareholding and/or to continue their investment in an open-ended vehicle managed by Axiom (the "Proposals"). That vehicle will have a similar investment strategy to that which the Company would have proposed if it were to continue to operate as a closed-ended listed investment company. In order to effect the Proposals it is expected that the existing Company will be liquidated.

The Board, together with Axiom and the Company's broker, Winterflood Securities Limited, is working on formal proposals to be put to Shareholders and will make a further announcement with details in due course. The Board's aim is for the proposals to be put to Shareholders early in 2023 and, assuming Shareholder approval is received, for the transaction to be completed as soon as reasonably practicable thereafter.

LEI: 54930084Q2LJS2LB1V76

The person responsible for making this announcement is Kevin Robins tel 01481 810 100.

For further information please contact:

Axiom Alternative Investments SARL

David Benamou, Managing Partner

 

+44(0)20 3807 0670

Winterflood Securities Limited

Neil Morgan

+44(0)20 3100 0000

 

Further details of the Company can be found on its website https://axiom-ai.com/web/en/axiom-european-financial-debt-fund-limited-2

Important Notice

This announcement is not intended to, and does not, constitute or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction, whether pursuant to this announcement or otherwise.

 

The release, distribution or publication of this announcement in jurisdictions outside the United Kingdom may be restricted by laws of the relevant jurisdictions and therefore persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities law of any such jurisdiction.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFITTVIDLIF
Date   Source Headline
5th Apr 20234:38 pmRNSNet Asset Value(s)
4th Apr 20234:25 pmRNSNet Asset Value(s)
4th Apr 202310:55 amRNSNet Asset Value(s)
31st Mar 20235:26 pmRNSNet Asset Value(s)
30th Mar 20235:01 pmRNSNet Asset Value(s)
29th Mar 20234:33 pmRNSNet Asset Value(s)
28th Mar 20234:53 pmRNSNet Asset Value(s)
28th Mar 20234:52 pmRNSNet Asset Value(s)
24th Mar 20235:05 pmRNSNet Asset Value(s)
23rd Mar 20235:14 pmRNSNet Asset Value(s)
23rd Mar 20238:21 amRNSNet Asset Value(s)
22nd Mar 20237:00 amRNSAnnual Financial Report
21st Mar 20235:58 pmRNSNet Asset Value Estimate and Credit Suisse Impact
20th Mar 20234:31 pmRNSNet Asset Value(s)
17th Mar 20235:25 pmRNSNet Asset Value(s)
16th Mar 20234:38 pmRNSNet Asset Value(s)
15th Mar 20235:34 pmRNSNet Asset Value(s)
15th Mar 202312:01 pmRNSMonthly Factsheet
14th Mar 20233:55 pmRNSNet Asset Value(s)
13th Mar 20235:08 pmRNSNet Asset Value(s)
10th Mar 20235:12 pmRNSNet Asset Value(s)
10th Mar 20235:11 pmRNSNet Asset Value(s)
8th Mar 20234:38 pmRNSNet Asset Value(s)
7th Mar 20234:48 pmRNSNet Asset Value(s)
7th Mar 20234:47 pmRNSNet Asset Value(s)
3rd Mar 20234:54 pmRNSNet Asset Value(s)
3rd Mar 20234:53 pmRNSNet Asset Value(s)
2nd Mar 20238:37 amRNSNet Asset Value(s)
1st Mar 20238:39 amRNSNet Asset Value(s)
28th Feb 20238:52 amRNSNet Asset Value(s)
24th Feb 20233:33 pmRNSNet Asset Value(s)
24th Feb 20233:30 pmRNSNet Asset Value(s)
22nd Feb 20233:51 pmRNSNet Asset Value(s)
22nd Feb 20233:48 pmRNSNet Asset Value(s)
20th Feb 20235:32 pmRNSMonthly Factsheet
20th Feb 20235:14 pmRNSNet Asset Value(s)
17th Feb 20235:05 pmRNSNet Asset Value(s)
16th Feb 20235:25 pmRNSNet Asset Value(s)
15th Feb 20235:33 pmRNSNet Asset Value(s)
14th Feb 20234:52 pmRNSNet Asset Value(s)
13th Feb 20234:23 pmRNSNet Asset Value(s)
10th Feb 20234:29 pmRNSNet Asset Value(s)
9th Feb 20235:15 pmRNSNet Asset Value(s)
9th Feb 20235:13 pmRNSNet Asset Value(s)
7th Feb 20234:56 pmRNSNet Asset Value(s)
6th Feb 20234:59 pmRNSNet Asset Value(s)
3rd Feb 20234:21 pmRNSNet Asset Value(s)
2nd Feb 20234:36 pmRNSNet Asset Value(s)
2nd Feb 202311:36 amRNSNet Asset Value(s)
1st Feb 20238:51 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.